|  | |
| Names | |
|---|---|
| Preferred IUPAC name N-(6,11-Dihydrodibenzo[b,e]thiepin-11-yl)-4-[4-(4-fluorophenyl)piperazin-1-yl]butanamide | |
| Identifiers | |
| 3D model (JSmol) | |
| ChemSpider | 
 | 
| KEGG | 
 | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C28H30FN3OS | |
| Molar mass | 475.63 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Monatepil is a calcium channel blocker and α1-adrenergic receptor antagonist used as an antihypertensive.[1]
References
- ↑ Sugimoto T, Hosoki K, Karasawa T (July 1995). "Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil". Journal of Cardiovascular Pharmacology. 26 (1): 55–60. doi:10.1097/00005344-199507000-00009. PMID 7564365. S2CID 1548014.
| Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
|---|---|---|---|---|---|
| Other antagonists | 
 | ||||
| 
 | |||||
| Calcium | 
 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Potassium | 
 | ||||||||||||||||||||||||
| Sodium | 
 | ||||||||||||||||||||||||
| Chloride | 
 | ||||||||||||||||||||||||
| Others | 
 | ||||||||||||||||||||||||
| See also: Receptor/signaling modulators • Transient receptor potential channel modulators | |||||||||||||||||||||||||
| α1 | 
 | ||||
|---|---|---|---|---|---|
| α2 | 
 | ||||
| β | 
 | ||||
| 
 | |||||
| Classes | |
|---|---|
| Antidepressants (Tricyclic antidepressants (TCAs)) | 
 | 
| Antihistamines | 
 | 
| Antipsychotics | 
 | 
| Anticonvulsants | |
| Anticholinergics | |
| Others | 
 | 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

